Clozapine-induced hypersalivation and the alpha 2 adrenoceptor.
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D003000:Clonidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D008875:Middle Aged; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy; D012798:Sialorrhea / Q000139:chemically induced* / Q000188:drug therapy
D014150:Antipsychotic Agents; D018341:Receptors, Adrenergic, alpha-2; D003024:Clozapine; D003000:Clonidine; C025655:lofexidine